tiprankstipranks
Trending News
More News >
Essex Bio-Technology Limited (HK:1061)
:1061
Hong Kong Market
Advertisement

Essex Bio-Technology (1061) Ratios

Compare
0 Followers

Essex Bio-Technology Ratios

HK:1061's free cash flow for Q2 2025 was HK$0.89. For the 2025 fiscal year, HK:1061's free cash flow was decreased by HK$ and operating cash flow was HK$0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.81 1.54 2.16 2.24 2.20
Quick Ratio
1.73 1.46 2.02 2.10 1.96
Cash Ratio
0.79 0.63 0.97 0.97 0.99
Solvency Ratio
0.41 0.37 0.27 0.34 0.25
Operating Cash Flow Ratio
0.52 0.42 0.68 0.59 0.49
Short-Term Operating Cash Flow Coverage
5.28 1.44 3.64 2.67 1.49
Net Current Asset Value
HK$ 481.90MHK$ 341.50MHK$ 232.95MHK$ 418.23MHK$ 337.71M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.10 0.18 0.20 0.23
Debt-to-Equity Ratio
0.09 0.15 0.28 0.33 0.39
Debt-to-Capital Ratio
0.08 0.13 0.22 0.25 0.28
Long-Term Debt-to-Capital Ratio
0.04 0.02 0.18 0.19 0.20
Financial Leverage Ratio
1.40 1.47 1.57 1.65 1.70
Debt Service Coverage Ratio
4.54 1.41 2.39 2.39 1.22
Interest Coverage Ratio
93.18 27.68 24.24 47.22 167.02
Debt to Market Cap
0.06 0.19 0.20 0.20 0.23
Interest Debt Per Share
0.33 0.54 0.87 1.00 0.98
Net Debt to EBITDA
-0.80 -0.52 -0.17 -0.24 -0.13
Profitability Margins
Gross Profit Margin
89.75%90.20%90.26%85.23%81.16%
EBIT Margin
21.25%21.03%20.64%24.65%25.79%
EBITDA Margin
24.00%24.52%23.79%26.66%28.58%
Operating Profit Margin
19.21%18.18%21.10%26.60%24.27%
Pretax Profit Margin
22.55%20.28%19.76%24.09%25.65%
Net Profit Margin
18.40%16.13%17.11%21.13%22.38%
Continuous Operations Profit Margin
18.46%16.13%17.12%21.13%22.38%
Net Income Per EBT
81.61%79.55%86.58%87.71%87.27%
EBT Per EBIT
117.38%111.50%93.63%90.56%105.67%
Return on Assets (ROA)
9.68%9.73%8.31%12.08%9.04%
Return on Equity (ROE)
14.24%14.31%13.02%19.95%15.35%
Return on Capital Employed (ROCE)
14.03%15.39%12.92%20.04%13.08%
Return on Invested Capital (ROIC)
10.97%10.95%10.66%16.40%10.27%
Return on Tangible Assets
15.84%14.17%13.57%17.13%12.20%
Earnings Yield
10.50%19.70%9.35%12.12%8.87%
Efficiency Ratios
Receivables Turnover
2.71 0.00 0.00 0.00 0.00
Payables Turnover
23.26 15.81 12.05 54.17 4.18
Inventory Turnover
2.90 2.66 1.53 2.48 1.25
Fixed Asset Turnover
4.03 4.10 3.29 4.65 3.50
Asset Turnover
0.56 0.60 0.49 0.57 0.40
Working Capital Turnover Ratio
2.94 3.14 1.74 2.07 1.32
Cash Conversion Cycle
247.43 114.00 207.55 140.49 203.91
Days of Sales Outstanding
145.58 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
130.19 137.09 237.85 147.23 291.23
Days of Payables Outstanding
28.34 23.09 30.30 6.74 87.32
Operating Cycle
275.77 137.09 237.85 147.23 291.23
Cash Flow Ratios
Operating Cash Flow Per Share
0.65 0.59 0.67 0.71 0.52
Free Cash Flow Per Share
0.57 0.37 0.17 0.29 -0.03
CapEx Per Share
0.08 0.22 0.49 0.42 0.55
Free Cash Flow to Operating Cash Flow
0.88 0.62 0.26 0.40 -0.06
Dividend Paid and CapEx Coverage Ratio
3.54 2.02 1.13 1.38 0.86
Capital Expenditure Coverage Ratio
8.30 2.65 1.35 1.67 0.94
Operating Cash Flow Coverage Ratio
1.97 1.15 0.78 0.72 0.53
Operating Cash Flow to Sales Ratio
0.22 0.20 0.29 0.25 0.31
Free Cash Flow Yield
8.50%15.12%4.14%5.77%-0.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
9.76 5.08 10.69 8.25 11.27
Price-to-Sales (P/S) Ratio
1.79 0.82 1.83 1.74 2.52
Price-to-Book (P/B) Ratio
1.41 0.73 1.39 1.65 1.73
Price-to-Free Cash Flow (P/FCF) Ratio
9.20 6.62 24.14 17.34 -134.07
Price-to-Operating Cash Flow Ratio
8.14 4.12 6.30 6.98 8.25
Price-to-Earnings Growth (PEG) Ratio
0.66 0.20 -0.31 0.14 -0.42
Price-to-Fair Value
1.41 0.73 1.39 1.65 1.73
Enterprise Value Multiple
6.52 2.82 7.52 6.29 8.70
Enterprise Value
2.63B 1.18B 2.36B 2.75B 2.43B
EV to EBITDA
6.04 2.82 7.52 6.29 8.70
EV to Sales
1.52 0.69 1.79 1.68 2.48
EV to Free Cash Flow
10.39 5.59 23.60 16.69 -132.06
EV to Operating Cash Flow
7.33 3.48 6.16 6.72 8.12
Tangible Book Value Per Share
2.08 1.82 1.19 1.55 1.38
Shareholders’ Equity Per Share
3.72 3.37 3.02 3.01 2.47
Tax and Other Ratios
Effective Tax Rate
0.18 0.20 0.13 0.12 0.13
Revenue Per Share
2.93 2.99 2.30 2.84 1.69
Net Income Per Share
0.54 0.48 0.39 0.60 0.38
Tax Burden
0.82 0.80 0.87 0.88 0.87
Interest Burden
0.99 0.96 0.96 0.98 0.99
Research & Development to Revenue
0.02 0.02 0.02 0.01 <0.01
SG&A to Revenue
0.12 0.13 0.12 0.09 0.11
Stock-Based Compensation to Revenue
0.00 0.00 <0.01 <0.01 <0.01
Income Quality
1.15 1.23 1.47 1.04 1.19
Currency in HKD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis